Form EFFECT Quoin Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 3, 2025 |
| Accession Number: | 0001104659-25-029406 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EHang Reports Second Quarter 2026 Unaudited Financial Results
- AM Best to Host Analytical Briefing on Its Approach to Insurance Financial Strength Ratings; Federation of Afro-Asian Insurers & Reinsurers (FAIR) Secretary General a Featured Speaker
- J.D. Lewis III Celebrates His Birthday at The Lewis Law Group, P.A's New Office
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
